These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15183656)

  • 1. The role of molecular genetics in the pathogenesis and diagnosis of neonatal sepsis.
    Del Vecchio A; Laforgia N; Capasso M; Iolascon A; Latini G
    Clin Perinatol; 2004 Mar; 31(1):53-67. PubMed ID: 15183656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biology on the ICU. From understanding to treating sepsis.
    Winning J; Claus RA; Huse K; Bauer M
    Minerva Anestesiol; 2006 May; 72(5):255-67. PubMed ID: 16675935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of inflammation in age-related atherosclerosis: its relevance to pharmacogenomics.
    Grimaldi MP; Vasto S; Balistreri CR; di Carlo D; Caruso M; Incalcaterra E; Lio D; Caruso C; Candore G
    Ann N Y Acad Sci; 2007 Apr; 1100():123-31. PubMed ID: 17460170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of genomic polymorphisms on the course of sepsis: is there a concept for gene therapy?
    Stüber F
    J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S60-4. PubMed ID: 11251034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine promoter polymorphisms in severe sepsis.
    Stuber F; Klaschik S; Lehmann LE; Schewe JC; Weber S; Book M
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S416-20. PubMed ID: 16237640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic polymorphism and sepsis--is there a reason for optimism?
    Průcha M; Zazula R; Peková S
    Prague Med Rep; 2008; 109(2-3):113-26. PubMed ID: 19548592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of pro-inflammatory genes and prostate cancer risk: a pharmacogenomic approach.
    Caruso C; Balistreri CR; Candore G; Carruba G; Colonna-Romano G; Di Bona D; Forte GI; Lio D; Listì F; Scola L; Vasto S
    Cancer Immunol Immunother; 2009 Dec; 58(12):1919-33. PubMed ID: 19221747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal sepsis: confronting the challenge.
    Witek-Janusek L; Cusack C
    Crit Care Nurs Clin North Am; 1994 Jun; 6(2):405-19. PubMed ID: 7946196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor type 1 gene polymorphism and sepsis.
    Hermans PW; Hazelzet JA
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S453-8. PubMed ID: 16237647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular biology and immunopathogenetic mechanisms of sepsis].
    Průcha M
    Cas Lek Cesk; 2009; 148(2):86-90. PubMed ID: 19637444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics: state of the research and perspectives in clinical application.
    Severino G; Chillotti C; Stochino ME; Del Zompo M
    Neurol Sci; 2003 May; 24 Suppl 2():S146-8. PubMed ID: 12811615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms in sepsis.
    Dahmer MK; Randolph A; Vitali S; Quasney MW
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S61-73. PubMed ID: 15857562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and genomics in the critical care unit.
    Winkelman C
    Crit Care Nurs Clin North Am; 2008 Jun; 20(2):213-21, vi. PubMed ID: 18424350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of pro-inflammatory genes and Alzheimer's disease risk: a pharmacogenomic approach.
    Candore G; Balistreri CR; Grimaldi MP; Listì F; Vasto S; Chiappelli M; Licastro F; Colonna-Romano G; Lio D; Caruso C
    Mech Ageing Dev; 2007 Jan; 128(1):67-75. PubMed ID: 17116319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine responses and sudden infant death syndrome: genetic, developmental, and environmental risk factors.
    Blackwell CC; Moscovis SM; Gordon AE; Al Madani OM; Hall ST; Gleeson M; Scott RJ; Roberts-Thomson J; Weir DM; Busuttil A
    J Leukoc Biol; 2005 Dec; 78(6):1242-54. PubMed ID: 16204631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of tacrolimus and sirolimus in renal transplant patients: from retrospective analyses to prospective studies.
    Anglicheau D; Legendre C; Thervet E
    Transplant Proc; 2007 Sep; 39(7):2142-4. PubMed ID: 17889118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics.
    Johnson AD; Wang D; Sadee W
    Pharmacol Ther; 2005 Apr; 106(1):19-38. PubMed ID: 15781120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New technologies for the rapid diagnosis of neonatal sepsis.
    Srinivasan L; Harris MC
    Curr Opin Pediatr; 2012 Apr; 24(2):165-71. PubMed ID: 22273634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.